CN111904918A - 一种皮肤美白焕亮组合物及其应用 - Google Patents
一种皮肤美白焕亮组合物及其应用 Download PDFInfo
- Publication number
- CN111904918A CN111904918A CN202010701211.3A CN202010701211A CN111904918A CN 111904918 A CN111904918 A CN 111904918A CN 202010701211 A CN202010701211 A CN 202010701211A CN 111904918 A CN111904918 A CN 111904918A
- Authority
- CN
- China
- Prior art keywords
- extract
- whitening
- skin whitening
- active matter
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 238000005282 brightening Methods 0.000 title claims abstract description 16
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 8
- 230000002195 synergetic effect Effects 0.000 claims abstract description 8
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 5
- 239000008280 blood Substances 0.000 claims abstract description 5
- 210000004369 blood Anatomy 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 230000004224 protection Effects 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 36
- 239000013543 active substance Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- VGMJYYDKPUPTID-UHFFFAOYSA-N 4-ethylbenzene-1,3-diol Chemical compound CCC1=CC=C(O)C=C1O VGMJYYDKPUPTID-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 4
- 235000006708 antioxidants Nutrition 0.000 claims description 4
- 230000003711 photoprotective effect Effects 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 2
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- DWVXFVWWARTDCQ-UHFFFAOYSA-N 2-ethylbenzene-1,3-diol Chemical compound CCC1=C(O)C=CC=C1O DWVXFVWWARTDCQ-UHFFFAOYSA-N 0.000 claims description 2
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 claims description 2
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 claims description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- 244000223014 Syzygium aromaticum Species 0.000 claims description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 2
- 244000299461 Theobroma cacao Species 0.000 claims description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 241000121220 Tricholoma matsutake Species 0.000 claims description 2
- 240000000377 Tussilago farfara Species 0.000 claims description 2
- 235000004869 Tussilago farfara Nutrition 0.000 claims description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 2
- 229960000458 allantoin Drugs 0.000 claims description 2
- 229940069521 aloe extract Drugs 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 claims description 2
- 229940033280 alpha-arbutin Drugs 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 2
- 230000003064 anti-oxidating effect Effects 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000001046 cacaotero Nutrition 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 235000001785 ferulic acid Nutrition 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 2
- 229940114124 ferulic acid Drugs 0.000 claims description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 2
- 229940093915 gynecological organic acid Drugs 0.000 claims description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- -1 serum Substances 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 150000003505 terpenes Chemical class 0.000 claims description 2
- 235000007586 terpenes Nutrition 0.000 claims description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 2
- 241000565319 Butea monosperma Species 0.000 claims 1
- 206010040829 Skin discolouration Diseases 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 12
- 239000000049 pigment Substances 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000001556 precipitation Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 230000019612 pigmentation Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000032400 Retinal pigmentation Diseases 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种皮肤美白焕亮组合物，由光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物组成，各成分重量比光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物为10％‑30％:20％‑40％:20％‑40％:5％‑15％：5％‑15％。一种皮肤美白焕亮组合物在配制皮肤美白化妆品中的应用。现有技术只能从黑色素的生成到沉淀过程进行干预改善肤色，本发明可以从根源上改善皮肤健康循环，加速色素以及自由基的代谢、改善色素沉着，同时减少色素生成；再辅以深度保湿补水，让细胞富有自我修护力，健康协同增效美白。
Description
技术领域
本发明涉及化妆品技术领域，具体是指一种皮肤美白焕亮组合物及其应用。
背景技术
《中国美容业市场调查报告》显示，目前50％的女性换新皮肤美白。随着年龄增长，光线暴露(例 UVA/UVB/蓝光/红外线等)，环境污染，生活工作压力等原因导致肌肤负担加重，引发自由基以及炎症反应， 从而加剧黑色素生成沉淀。
传统美白类化妆品通过物理遮盖、或者剥脱角质层及其中色素达到美白。美白类护肤品主要着手于解 决黑色素的生成以及转移过程控制，常见手段有阻止色素生成，阻断色素迁移、阻隔色素沉淀三种方法。 以上方法可以一定程度上让肌肤改善色沉、提升肤色，但是无法解决肌肤光泽、干燥缺水、人体内分泌系 统失调、人体代谢节奏不平衡等问题。
发明内容
本发明要解决的技术问题是克服以上技术缺陷，提供一种皮肤美白焕亮组合物及其应用。
为了达到上述发明目的，本发明采用的技术方案为：一种皮肤美白焕亮组合物，由光防护活性物、 增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物组成，各成分重量比光防护活性物、 增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物为10％-30％:20％-40％:20％-40％:5％-15％： 5％-15％。
进一步的，各成分重量比光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补 水活性物为20％：30％:30％:10％:10％。
进一步的，所述光防护活性物：芦荟提取物、可可籽提取物、黄芩提取物、款冬花、丁香提取物、 脐形紫菜提取物；所述增效美白活性物：鸡血藤提取物(紫铆黄铜)、黄芪提取物(毛蕊异黄铜)、松茸提 取物(粘多糖、蛋白质、氨基酸、甾类、萜类)、Alpha-熊果苷、烟酰胺、4-乙基间苯二酚、白及提取物(联 苄&白及多糖)、本乙基间苯二酚；所述抗氧化活性物：白藜芦醇提取物、牛舌草提取物(有机酸：阿魏酸、 丁二酸、菸酸等)、甘草提取物、积雪草提取物、抗坏血酸乙基醚、3-o-乙基抗坏血酸(VC)、SOD；所述 补气盛血活性物：茯苓提取物、白术提取物、当归提取物、白芍提取物、桃仁提取物、红花提取物、肉桂 提取物；所述保湿补水活性物：1,2戊二醇、甘油、果糖、尿素、麦芽糖、海藻糖、尿囊素、透明质酸钠、 葡萄糖、甜菜碱、甘油聚醚-26。
一种皮肤美白焕亮组合物应用，权利要求1-3任意一项在配制皮肤美白化妆品中的应用。
进一步的，所述皮肤美白化妆品的类型包括凝胶、膏霜、浆液、水剂、乳液或固体。
进一步的，所述皮肤美白化妆品在最终产品中的含量为0.1-10％。
进一步的，所述皮肤美白化妆品在乳液中的添加含量为3-8％。
进一步的，所述皮肤美白化妆品在膏霜中的添加含量为4-9％。
本发明的有益效果为：
1、现有技术只能从黑色素的生成到沉淀过程进行干预改善肤色，本发明可以从根源上改善皮肤健康 循环，加速色素以及自由基的代谢、改善色素沉着，同时减少色素生成；再辅以深度保湿补水，让细胞富 有自我修护力，健康协同增效美白；
2、本发明从黑色素生成前的肌肤环境干预，到黑色素生成过程中的干预，到皮肤循环代谢效率干预 三个方面同步进行，产生协同增效；
3、本发明结合中药组方以及纯化西药制剂，可不受制于美白活性成分添加量上限，进一步加强产品 功效；
4、本发明减少活性成分刺激性，从而更加安全；
5、本发明的焕亮组何物无剂型限制，可以用于溶液、乳液、膏霜、悬浮液、散粉、粉饼等剂型。本 复合美白液可以在美白化妆品中应用，也可以根据需要适当的配合其它成分使用，例如其它美白剂、保湿 剂、表面活性剂、多元醇类、螯合剂、防腐剂、水等基质成份。
具体实施方式
为了使本发明的内容更容易被清楚地理解，下面对本发明实施例中的技术方案进行清楚、完整地描述。 1、皮肤美白焕亮组合物的配方
实施例一和实施例二
2、皮肤美白焕亮组合物在配制皮肤美白化妆品中的应用
2.1、一款具有美白焕亮功效的水
2.2、一款具有美白焕亮功效的乳
2.3、一款具有美白焕亮功效的精华
2.4、一款具有美白焕亮功效的原液
2.5、一款具有美白焕亮功效的膏霜
3、临床试用效果评估：
测试对象：选择20名志愿者(女性25-50岁)；
使用方法：在每晚睡前清洁手臂内侧，并蘸取少量产品(约0.1g)涂于左手臂内侧同一部位，轻轻 涂抹至产品被皮肤吸收，右手不涂作为空白对照，发放调查表，试用者根据自己的主观感觉给予评价项目 分值(0～10分)，计算各项平均值。
使用疗程：连续使用6周；
疗效判断：CBS-902皮肤检测仪每周检测1次，记录皮肤色素含量、皮肤含水量的变化情况。
试用结果：试用期间20名志愿者均未出现过敏等不良反应，试用前后20名志愿者皮肤油分等指标 无明显变化，皮肤水分改善明显，结果表明，本配方具有较好的滋润效果和愉悦的肤感，且有明显美白效 果。
以上对本发明及其实施方式进行了描述，这种描述没有限制性，只是本发明的实施方式之一，实际的 实施方式并不局限于此。总而言之如果本领域的普通技术人员受其启示，在不脱离本发明创造宗旨的情况 下，不经创造性的设计出与该技术方案相似的实施例，均应属于本发明的保护范围。
Claims (8)
1.一种皮肤美白焕亮组合物，其特征在于：由光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物组成，各成分重量比光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物为10％-30％:20％-40％:20％-40％:5％-15％：5％-15％。
2.根据权利要求1所述的一种皮肤美白焕亮组合物，其特征在于：各成分重量比光防护活性物、增效美白活性物、抗氧化活性物、补气盛血活性物、保湿补水活性物为20％：30％:30％:10％:10％。
3.根据权利要求1所述的一种皮肤美白焕亮组合物，其特征在于：
所述光防护活性物：芦荟提取物、可可籽提取物、黄芩提取物、款冬花、丁香提取物、脐形紫菜提取物；
所述增效美白活性物：鸡血藤提取物(紫铆黄铜)、黄芪提取物(毛蕊异黄铜)、松茸提取物(粘多糖、蛋白质、氨基酸、甾类、萜类)、Alpha-熊果苷、烟酰胺、4-乙基间苯二酚、白及提取物(联苄&白及多糖)、本乙基间苯二酚；
所述抗氧化活性物：白藜芦醇提取物、牛舌草提取物(有机酸：阿魏酸、丁二酸、菸酸等)、甘草提取物、积雪草提取物、抗坏血酸乙基醚、3-o-乙基抗坏血酸(VC)、SOD；
所述补气盛血活性物：茯苓提取物、白术提取物、当归提取物、白芍提取物、桃仁提取物、红花提取物、肉桂提取物；
所述保湿补水活性物：1,2戊二醇、甘油、果糖、尿素、麦芽糖、海藻糖、尿囊素、透明质酸钠、葡萄糖、甜菜碱、甘油聚醚-26。
4.一种皮肤美白焕亮组合物应用，其特征在于：权利要求1-3任意一项在配制皮肤美白化妆品中的应用。
5.根据权利要求4所述的一种皮肤美白焕亮组合物应用，其特征在于：所述皮肤美白化妆品的类型包括凝胶、膏霜、浆液、水剂、乳液或固体。
6.根据权利要求4所述的一种皮肤美白焕亮组合物应用，其特征在于：所述皮肤美白化妆品在最终产品中的含量为0.1-10％。
7.根据权利要求1所述的一种皮肤美白焕亮组合物应用，其特征在于：所述皮肤美白化妆品在乳液中的添加含量为3-8％。
8.根据权利要求1所述的一种皮肤美白焕亮组合物应用，其特征在于：所述皮肤美白化妆品在膏霜中的添加含量为4-9％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010701211.3A CN111904918A (zh) | 2020-07-20 | 2020-07-20 | 一种皮肤美白焕亮组合物及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010701211.3A CN111904918A (zh) | 2020-07-20 | 2020-07-20 | 一种皮肤美白焕亮组合物及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111904918A true CN111904918A (zh) | 2020-11-10 |
Family
ID=73281707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010701211.3A Pending CN111904918A (zh) | 2020-07-20 | 2020-07-20 | 一种皮肤美白焕亮组合物及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111904918A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496775A (zh) * | 2009-02-26 | 2009-08-05 | 徐伟玲 | 一种面部化妆品 |
| CN106074677A (zh) * | 2016-08-05 | 2016-11-09 | 山东大学 | 一种防治皮肤病变老化的中药组合物及其应用 |
| CN106137823A (zh) * | 2015-04-28 | 2016-11-23 | 张文燕 | 一种美白祛斑组合物及其应用 |
| CN107080726A (zh) * | 2017-04-26 | 2017-08-22 | 无限极（中国）有限公司 | 一种皮肤美白方案及其应用 |
| CN108815037A (zh) * | 2018-08-02 | 2018-11-16 | 广州航美化妆品有限公司 | 一种美白焕颜护肤组合物及其在化妆品中的应用 |
-
2020
- 2020-07-20 CN CN202010701211.3A patent/CN111904918A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496775A (zh) * | 2009-02-26 | 2009-08-05 | 徐伟玲 | 一种面部化妆品 |
| CN106137823A (zh) * | 2015-04-28 | 2016-11-23 | 张文燕 | 一种美白祛斑组合物及其应用 |
| CN106074677A (zh) * | 2016-08-05 | 2016-11-09 | 山东大学 | 一种防治皮肤病变老化的中药组合物及其应用 |
| CN107080726A (zh) * | 2017-04-26 | 2017-08-22 | 无限极（中国）有限公司 | 一种皮肤美白方案及其应用 |
| CN108815037A (zh) * | 2018-08-02 | 2018-11-16 | 广州航美化妆品有限公司 | 一种美白焕颜护肤组合物及其在化妆品中的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411681B (zh) | 中药美白祛斑面膜粉及其制备方法 | |
| CN110090191B (zh) | 一种晒后修复组合物及其化妆品 | |
| CN1824133A (zh) | 一种治疗脱发的药物组合物及其制备方法 | |
| KR101669651B1 (ko) | 홍삼 마스크팩용 조성물, 그 제조방법, 및 이에 의해 제조된 마스크팩 | |
| CN112043661B (zh) | 一种美白芦荟胶及其制备方法 | |
| CN110604718A (zh) | 一种全效多肽眼部精华及其制备方法 | |
| CN113134089A (zh) | 一种含有生物多糖的组合物及其应用 | |
| CN112569152A (zh) | 一种控油抗炎的植物组合提取物及其制备方法和应用 | |
| CN111494496A (zh) | 一种生发乌发的中药组合物、其制备方法及应用 | |
| CN106511211B (zh) | 一种抗炎祛痘护肤乳液及其制备方法 | |
| CN109512744B (zh) | 一种睫毛生长液及其制备方法 | |
| CN113288854A (zh) | 一种中药配方抗衰老美白保湿面膜及其制备方法 | |
| CN111329829A (zh) | 一种中药面膜及其制备方法 | |
| CN110559231A (zh) | 一种美白、祛斑精华液及其制备方法 | |
| CN107898749B (zh) | 一种具有护肤功效的外用组合物及其制备方法 | |
| CN111904918A (zh) | 一种皮肤美白焕亮组合物及其应用 | |
| CN105342966A (zh) | 含有日本医蛭的护肤保湿霜及其制备方法 | |
| CN114569523A (zh) | 一种含双萃蛋白的抗皱护肤品及使用方法 | |
| CN106390061A (zh) | 一种外用防脱、育发的毛囊干细胞唤醒因子的组合物及其制备方法 | |
| CN111514075A (zh) | 一种防晒组合物及其应用 | |
| CN111759919A (zh) | 一种祛斑中药组合物及其制备方法、祛斑中药面霜及其制备方法 | |
| CN110478285B (zh) | 一种抗头皮衰老的组合物 | |
| CN108354879A (zh) | 一种祛痘防感染的面霜及其制备方法 | |
| CN115804745B (zh) | 一种皮肤护理舒缓修护组合物及其应用 | |
| CN1095286A (zh) | 抗衰美容液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201110 |
|
| RJ01 | Rejection of invention patent application after publication |